Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas
Authors:
- 1 December 2009
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (12) , 1555-1563
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Histopathologic Examination and Reporting of Esophageal Carcinomas Following Preoperative Neoadjuvant TherapyAmerican Journal of Clinical Pathology, 2008
- Induction Chemotherapy in Barrett CancerAnnals of Surgery, 2007
- Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisThe Lancet Oncology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer staging systemThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2006
- Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its TreatmentAnnals of Surgical Oncology, 2006
- Association of Pretherapeutic Expression of Chemotherapy-Related Genes with Response to Neoadjuvant Chemotherapy in Barrett CarcinomaClinical Cancer Research, 2005
- Tumor response to induction chemoradiation: influence on survival after esophagectomy☆European Journal of Cardio-Thoracic Surgery, 2003